☰

Joyonna Gamble-George, Ph.D. - Publications

Affiliations: 
2007-2009 VA Bay Pines Healthcare System 
 2007-2009 University of South Florida, Tampa, FL, United States 
 2009-2011 Meharry Medical College, Nashville, TN, United States 
 2011-2016 Vanderbilt University, Nashville, TN 
 2016-2018 University of Florida College of Medicine/McKnight Brain Institute 
 2019-2021 National Institutes of Health, Bethesda, MD 
Website:
https://www.joyonnagamble.com/
Tree Info Grants Similar researchers PubMed Report error

26/26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ransome Y, Hayashi K, Gamble-George JC, Dean LT, Villalonga-Olives E. Racial and ethnic differences in the association of social cohesion and social capital with HIV testing. Ssm - Population Health. 21: 101327. PMID 36618543 DOI: 10.1016/j.ssmph.2022.101327  0.044
2022 Jimenez J, Gamble-George J, Danies G, Hamm RL, Porras AM. Public Engagement with Biotechnology Inside and Outside the Classroom: Community-Focused Approaches. Gen Biotechnology. 1: 346-354. PMID 36032190 DOI: 10.1089/genbio.2022.0024  0.057
2021 Opara I, Malik S, Lardier DT, Gamble-George J, Kelly RJ, Okafor CN, Greene RN, Parisi D. Alcohol Use Cravings as a Mediator Between Associated Risk Factors on Increased Alcohol Use among Youth Adults in New York During the COVID-19 Pandemic. Alcoholism Treatment Quarterly. 39: 415-429. PMID 34898835 DOI: 10.1080/07347324.2021.1950091  0.085
2021 Lin M, Mackie PM, Shaerzadeh F, Gamble-George J, Miller DR, Martyniuk CJ, Khoshbouei H. In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition. Acta Neuropathologica Communications. 9: 107. PMID 34099060 DOI: 10.1186/s40478-021-01203-9  0.135
2021 Greenwood GL, Wilson A, Bansal GP, Barnhart C, Barr E, Berzon R, Boyce CA, Elwood W, Gamble-George J, Glenshaw M, Henry R, Iida H, Jenkins RA, Lee S, Malekzadeh A, et al. HIV-Related Stigma Research as a Priority at the National Institutes of Health. Aids and Behavior. PMID 33886010 DOI: 10.1007/s10461-021-03260-6  0.032
2020 Varagic J, Desvigne-Nickens P, Gamble-George J, Hollier L, Maric-Bilkan C, Mitchell M, Pemberton VL, Redmond N. Maternal Morbidity and Mortality: Are We Getting to the "Heart" of the Matter? Journal of Women's Health (2002). PMID 33259740 DOI: 10.1089/jwh.2020.8852  0.063
2020 Gamble-George JC, Redmond N, Boyce CA. Letter by Gamble-George et al Regarding Article, "Identification of Racial Inequities in Access to Specialized Inpatient Heart Failure Care at an Academic Medical Center". Circulation. Heart Failure. 13: e007171. PMID 32498622 DOI: 10.1161/CIRCHEARTFAILURE.120.007171  0.01
2020 Gamble-George JC, Longenecker CT, Webel AR, Au DH, Brown AF, Bosworth H, Crothers K, Cunningham WE, Fiscella KA, Hamilton AB, Helfrich CD, Ladapo JA, Luque A, Tobin JN, Wyatt GE; Implementation Research to Develop Interventions for People Living with HIV (PRECluDE) Consortium. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Progress in Cardiovascular Diseases. 63: 79-91. PMID 32199901 DOI: https://doi.org/10.1016/j.pcad.2020.03.006  0.058
2020 Gamble-George JC, Longenecker CT, Webel AR, Au DH, Brown AF, Bosworth H, Crothers K, Cunningham WE, Fiscella KA, Hamilton AB, Helfrich CD, Ladapo JA, Luque A, Tobin JN, Wyatt GE, et al. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Progress in Cardiovascular Diseases. PMID 32199901 DOI: 10.1016/J.Pcad.2020.03.006  0.058
2018 Miller DR, Shaerzadeh F, Phan L, Sharif N, Gamble-George J, McLaughlin JP, Streit WJ, Khoshbouei H. HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia. PMID 29733459 DOI: 10.1002/Glia.23447  0.118
2017 Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H. HIV, Tat and dopamine transmission. Neurobiology of Disease. 105: 51-73. PMID 28457951 DOI: https://doi.org/10.1016/j.nbd.2017.04.015  0.099
2016 Gamble-George JC, Baldi R, Halladay L, Kocharian A, Hartley N, Silva CG, Roberts H, Haymer A, Marnett LJ, Holmes A, Patel S. Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife. 5. PMID 27162170 DOI: 10.7554/Elife.14137  0.596
2016 Gamble-George JC, Baldi R, Halladay L, Kocharian A, Hartley N, Silva CG, Roberts H, Haymer A, Marnett LJ, Holmes A, Patel S. Author response: Cyclooxygenase-2 inhibition reduces stress-induced affective pathology Elife. DOI: 10.7554/Elife.14137.024  0.519
2014 Butler B, Gamble-George J, Prins P, North A, Clarke JT, Khoshbouei H. Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice. Journal of Addiction & Prevention. 2. PMID 25621291  0.119
2014 Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S. Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Translational Psychiatry. 4: e408. PMID 25004388 DOI: 10.1038/Tp.2014.53  0.58
2014 Hermanson DJ, Gamble-George JC, Marnett LJ, Patel S. Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. Trends in Pharmacological Sciences. 35: 358-67. PMID 24845457 DOI: 10.1016/J.Tips.2014.04.006  0.532
2014 Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, Watanabe M, Katona I, Patel S. Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron. 81: 1111-25. PMID 24607231 DOI: 10.1016/J.Neuron.2014.01.012  0.498
2013 Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, Colbran RJ, Reese J, Marnett LJ, Patel S. Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nature Neuroscience. 16: 1291-8. PMID 23912944 DOI: 10.1038/Nn.3480  0.578
2013 Gamble-George JC, Conger JR, Hartley ND, Gupta P, Sumislawski JJ, Patel S. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. Psychopharmacology. 228: 401-9. PMID 23483200 DOI: 10.1007/S00213-013-3042-8  0.511
2013 North A, Swant J, Salvatore MF, Gamble-George J, Prins P, Butler B, Mittal MK, Heltsley R, Clark JT, Khoshbouei H. Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. Synapse (New York, N.Y.). 67: 245-57. PMID 23280858 DOI: 10.1002/Syn.21635  0.253
2013 Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry. 18: 813-23. PMID 22688188 DOI: 10.1038/Mp.2012.72  0.57
2011 Swant J, Goodwin JS, North A, Ali AA, Gamble-George J, Chirwa S, Khoshbouei H. α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. The Journal of Biological Chemistry. 286: 43933-43. PMID 21990355 DOI: 10.1074/Jbc.M111.241232  0.264
2009 Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash GW. Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience. 162: 1220-31. PMID 19447162 DOI: 10.1016/J.Neuroscience.2009.05.019  0.321
2008 Echeverria V, Burgess S, Gamble-George J, Arendash GW, Citron BA. Raf inhibition protects cortical cells against beta-amyloid toxicity. Neuroscience Letters. 444: 92-6. PMID 18706973 DOI: 10.1016/J.Neulet.2008.07.092  0.327
2008 Moran VE, Gamble-George J, Burgess S, Dickson A, Mamcarz M, Arendash GW. P4-303: Sorafenib as a therapeutic agent against Alzheimer's disease Alzheimer's & Dementia. 4: T760-T760. DOI: 10.1016/J.Jalz.2008.05.2373  0.205
2008 Burgess S, Zeitlin R, Gamble-George J, Moran VE. P2-319: Cotinine is neuroprotective against beta-amyloid toxicity Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1396  0.205
Hide low-probability matches.